SCHEMBL18659611

SCHEMBL18659611

NC(=O)[C@H](CCCCNC(=O)OCc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NCl

nearest known ligand 0.66

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.66
▸ SIRT2 Q8IXJ6 1/20 0.57
▸ FOLH1 Q04609 2/20 0.57
▸ PTGER4 P35408 3/20 0.54
▸ CPB1 P15086 1/20 0.53
▸ CPB2 Q96IY4 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ MMP2 P08253 1/20 0.52
▸ MMP9 P14780 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ ANPEP P15144 1/20 0.51
▸ SIRT5 Q9NXA8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17073781 0.89 CTSL (0.63) CTSLSIRT2FOLH1CPB1CPB2
SCHEMBL18655442 0.88 CTSL (0.59) CTSLSIRT2FOLH1PTGER4CPB1
SCHEMBL18659633 0.88 CTSL (0.62) CTSLSIRT2FOLH1PTGER4CPB1
SCHEMBL18659557 0.88 CTSL (0.55) CTSLSIRT2FOLH1PTGER4CPB1
SCHEMBL18258354 0.87 CTSL (0.52) CTSLSIRT2FOLH1PTGER4CPB1
SCHEMBL17073778 0.87 CTSL (0.64) CTSLSIRT2
SCHEMBL16869913 0.87 ANPEP (0.61) CTSLSIRT2FOLH1CPB1CPB2
SCHEMBL20794742 0.86 ANPEP (0.60) CTSLSIRT2FOLH1CPB1CPB2
SCHEMBL31679032 0.86 CTSL (0.62) CTSLSIRT2FOLH1PTGER4ANPEP
SCHEMBL20653746 0.85 CTSL (0.67) CTSLSIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170081363-A1 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES STEALTH BIOTHERAPEUTICS CORP (MC) 2017-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081363-A1 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES ADM2, VIP, ANPEP CTSL 200/4885SIRT2 2787/4885FOLH1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback